This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Nissan Chemical Industries Limited. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Minami-saitama-gun, JP (2013)
- Shiraoka, JP (2015)
Company Filing History:
Years Active: 2013-2015
Title: Kazuya Takeuchi: Innovator in Organic Chemistry
Introduction
Kazuya Takeuchi is a prominent inventor based in Shiraoka, Japan. He has made significant contributions to the field of organic chemistry, particularly in the development of novel compounds with potential therapeutic applications. With a total of 2 patents to his name, Takeuchi continues to push the boundaries of innovation in his field.
Latest Patents
Takeuchi's latest patents include groundbreaking work on organic amine salts of aminobenzoic acid derivatives. This patent describes a novel organic amine salt or salt with quaternary ammonium ion of 3-{[((2E)-2-{1-[5-(4-t-butylphenyl)-4-hydroxy-3-thienyl]ethylidene}hydrazino)carbonothioyl]amino}benzoic acid, which has useful properties as a drug. Additionally, he has developed pyridazinone compounds that act as P2X7 receptor inhibitors, which are valuable for the prevention and treatment of inflammatory and immunological diseases.
Career Highlights
Kazuya Takeuchi is currently employed at Nissan Chemical Industries Limited, where he applies his expertise in organic chemistry to develop innovative solutions. His work has garnered attention in the scientific community, and he is recognized for his contributions to drug development.
Collaborations
Takeuchi collaborates with talented colleagues, including Shunsuke Iwamoto and Satoshi Nakano. These partnerships enhance the research and development efforts at Nissan Chemical Industries Limited, fostering a collaborative environment for innovation.
Conclusion
Kazuya Takeuchi is a notable inventor whose work in organic chemistry has the potential to impact the pharmaceutical industry significantly. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile